• Trials and Research

  Vumerity Approved for RRMS, Active SPMS in US, Biogen Announces

  Posted by MS News Today Moderator on November 7, 2019 at 9:17 am

  The U.S. Food and Drug Administration has approved Vumerity (diroximel fumarate) for the treatment of relapsing forms of multiple sclerosis (MS). Read more about it here.

  What do you think of this news?

  MS News Today Moderator replied 4 years, 5 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply